DETERMINATION OF TISSUE-SPECIFICITY OF THE ENHANCER BY COMBINATORIAL OPERATION OF TISSUE-ENRICHED TRANSCRIPTION FACTORS - BOTH HNF-4 AND C EBP-BETA ARE REQUIRED FOR LIVER-SPECIFIC ACTIVITY OF THE ORNITHINE TRANSCARBAMYLASE ENHANCER/
A. Nishiyori et al., DETERMINATION OF TISSUE-SPECIFICITY OF THE ENHANCER BY COMBINATORIAL OPERATION OF TISSUE-ENRICHED TRANSCRIPTION FACTORS - BOTH HNF-4 AND C EBP-BETA ARE REQUIRED FOR LIVER-SPECIFIC ACTIVITY OF THE ORNITHINE TRANSCARBAMYLASE ENHANCER/, The Journal of biological chemistry, 269(2), 1994, pp. 1323-1331
The enhancer of the rat ornithine transcarbamylase gene is located 11
kilobases upstream from the transcription start site and has been show
n to be hepatoma cell-specific. Using transgenic mice, we showed that
this enhancer is capable of activating transcription in a liver-specif
ic manner, inverting the tissue specificity of the homologous promoter
that is by itself more active in the small intestine than in the live
r. Transient transfection analysis with cultured hepatoma cells indica
ted that the enhancer activity resides in the approximately 110-base p
air region containing four protein-binding sites, two for hepatocyte n
uclear factor-4 (HNF-4) and two for CCAAT/enhancer binding protein (C/
EBP), both of which are liver-selective transcription factors. Concate
merization of a region containing one HNF-4 and one C/EBP site led to
reconstitution of the hepatoma cell-specific enhancer, and intactness
of these two sites was strictly required for the enhancer activity. Fu
rthermore, cotransfection experiments showed that both HNF-4 and C/EBP
beta are necessary, and neither alone sufficient, for activation of th
e reconstituted enhancer in nonhepatic cells. Requirement of combinato
rial operation of at least two liver-enriched transcription factors fo
r transcriptional activation successfully explains why these liver-sel
ective but not strictly liver-specific factors can confer more restric
ted liver specificity on transcription of their target genes.